Search Results - "Kranjac, Carlene A"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer by Iida, Mari, McDaniel, Nellie K, Kostecki, Kourtney L, Welke, Noah B, Kranjac, Carlene A, Liu, Peng, Longhurst, Colin, Bruce, Justine Y, Hong, Seungpyo, Salgia, Ravi, Wheeler, Deric L

    Published in BMC cancer (23-04-2022)
    “…The receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR) is overexpressed and an important therapeutic target in Head and Neck cancer (HNC)…”
    Get full text
    Journal Article
  2. 2

    MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer by Iida, Mari, Crossman, Bridget E, Kostecki, Kourtney L, Glitchev, Christine E, Kranjac, Carlene A, Crow, Madisen T, Adams, Jillian M, Liu, Peng, Ong, Irene, Yang, David T, Kang, Irene, Salgia, Ravi, Wheeler, Deric L

    “…Triple-negative breast cancer (TNBC) is characterized by the absence of the estrogen receptor, progesterone receptor, and receptor tyrosine kinase HER2…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Abstract 1334: MerTK tumorigenesis and immune evasion mechanisms in triple negative breast cancer by Iida, Mari, Kostecki, Kourtney, Kranjac, Carlene A., Glitchev, Christine, Yang, David T., Wheeler, Deric L.

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Triple negative breast cancer (TNBC) cells lack estrogen, progesterone, and HER2 receptors. TNBC tends to be more aggressive than most types of breast…”
    Get full text
    Journal Article
  5. 5

    Abstract 6994: MerTK drives proliferation and metastasis activity in triple negative breast cancer by Glitchev, Christine, Iida, Mari, Crossman, Bridget E., Kostecki, Kourtney L., Kranjac, Carlene A., Adams, Jillian M., Liu, Peng, Ong, Irene, Yang, David T., Kang, Irene, Salgia, Ravi, Wheeler, Deric L.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Triple negative breast cancer (TNBC) is characterized by the absence of estrogen, progesterone, and HER2 receptors. It exhibits a higher level of…”
    Get full text
    Journal Article